Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 011284
Company: MEDPOINTE PHARM HLC
Company: MEDPOINTE PHARM HLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MEPROSPAN | MEPROBAMATE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
MEPROSPAN | MEPROBAMATE | 400MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |